Epac1 controls VE-cadherin-mediated cell junction formation and induces reorganization of the actin cytoskeleton in human endothelial cells.
Answers are grounded in this paper and cite their sources.
Epac1 may modulate endothelial barrier function in vitro; leaves open therapeutic targeting in vascular leak syndromes.
We have previously shown that Rap1 as well as its guanine nucleotide exchange factor Epac1 increases cell-cell junction formation. Here, we show that activation of Epac1 with the exchange protein directly activated by cAMP (Epac)-specific cAMP analog 8CPT-2'O-Me-cAMP (007) resulted in a tightening of the junctions and a decrease in the permeability of the endothelial cell monolayer. In addition, 007 treatment resulted in the breakdown of actin stress fibers and the formation of cortical actin. These effects were completely inhibited by siRNA against Epac1. In VE-cadherin knock-out cells Epac1 did not affect cell permeability, whereas in cells re-expressing VE-cadherin this effect was restored. Finally, the effect of Epac activation on the actin cytoskeleton was independent of junction formation. From these results we conclude that in human umbilical vein endothelial cells Epac1 controls VE-cadherin-mediated cell junction formation and induces reorganization of the actin cytoskeleton.
No takes yet. Share an insight, caveat, or question.
Kooistra et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: